Company intelligence / Profile preview

Impulse

Ownership: Private
Development stage: Other

Overview

Impulse Biomed develops affordable, sustainable medical devices aimed at improving access to healthcare in under-resourced settings. Their products include assistive attachments for asthma inhalers ("Easy Squeezy"), orthopedic diagnostic tools ("Laxmeter"), and safety devices for rural clinics. The company has received regulatory recognition such as the SAHPRA manufacturing license.

Therapeutic areas: PulmonologyRheumatologyImmunologyInfectious Diseases
Modalities: DeviceMedical device (general)Assistive technology for inhalers and orthopedics
Industry: Assistive Medical Devices

Partnerships

Recipient of ASPEN® Pharmaceutical’s Route to Market Challenge award

Beyond the preview

Go deeper on Impulse.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Impulse.

Explore the full profile